Notably, the loss of JAM-A has been implicated in changes to intestinal permeability with subsequent inflammation, cytokine production and colitis in mice (Laukoetter et al., 2007) and IBD in humans (Vetrano and Danese, 2009; Vetrano et al., 2008). Here, F11R is linked to colitis.